Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 8MG | TABLET | Resolved | 2021-02-25 | 2021-09-16 | 134743 |
| ACT ENALAPRIL | 2MG | TABLET | Resolved | 2018-09-12 | 2019-01-31 | 61346 |
| ACT ENALAPRIL | 16MG | TABLET | Resolved | 2023-02-02 | 2023-07-12 | 183395 |
| ACT ENALAPRIL | 2MG | TABLET | Resolved | 2021-05-13 | 2021-05-20 | 139297 |
| ACT ENALAPRIL | 8MG | TABLET | Resolved | 2023-06-08 | 2023-07-28 | 194113 |
| ACT ENALAPRIL | 8MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195475 |
| ACT ENALAPRIL | 2MG | TABLET | Resolved | 2024-11-08 | 2025-02-20 | 242355 |
| ACT ENALAPRIL | 2MG | TABLET | Resolved | 2019-10-31 | 2020-03-05 | 97602 |
| ACT ENALAPRIL | 16MG | TABLET | Resolved | 2021-03-25 | 2021-09-16 | 136283 |
| ACT ENALAPRIL | 2MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195469 |
| ACT ENALAPRIL | 8MG | TABLET | Resolved | 2018-09-12 | 2019-03-12 | 61343 |
| ACT ENALAPRIL | 4MG | TABLET | Resolved | 2018-09-12 | 2019-01-31 | 61352 |
| ACT ENALAPRIL | 2MG | TABLET | Resolved | 2020-07-16 | 2020-07-30 | 120482 |
| ACT ENALAPRIL | 2MG | TABLET | Resolved | 2023-04-27 | 2023-07-14 | 190776 |
| ACT ENALAPRIL | 16MG | TABLET | Resolved | 2017-08-24 | 2017-10-10 | 20326 |
| ACT ENALAPRIL | 16MG | TABLET | Resolved | 2023-06-19 | 2023-07-06 | 195646 |
| ACT ENALAPRIL | 4MG | TABLET | Resolved | 2021-04-08 | 2021-09-09 | 137203 |
| ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169995 |
| ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-06-09 | 169990 |
| ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-03-31 | 2022-06-17 | 157637 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| TEVA-RANITIDINE SOLUTION | 15MG | SOLUTION | Discontinued | 2019-04-11 | 2019-04-11 | 81304 |
| TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256079 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| TEVA-TECNAL C 1/4 | 330MG 50MG 15MG 40MG | CAPSULE | Discontinued | 2019-04-11 | 2019-04-11 | 81353 |
| TEVA-TENOFOVIR | 300MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256088 |
| TEVA-TOPISONE | 0.05% | LOTION | Discontinued | 2024-06-28 | 2024-06-29 | 231589 |
| TEVA-TOPOTECAN | 4MG | POWDER FOR SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256104 |
| TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120021 |
| TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120024 |
| TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120027 |
| TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120030 |
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Discontinued | 2020-01-21 | 2020-01-21 | 103788 |
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14060 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |